Found 4 results
Filters: Keyword is Histocompatibility Antigens Class II  [Clear All Filters]
2017
Ott PA, Hu Z, Keskin DB, Shukla SA, Sun J, Bozym DJ, Zhang W, Luoma A, Giobbie-Hurder A, Peter L et al..  2017.  An immunogenic personal neoantigen vaccine for patients with melanoma.. Nature. 547(7662):217-221.
DeBerge M, Yeap XYi, Dehn S, Zhang S, Grigoryeva L, Misener S, Procissi D, Zhou X, Lee DC, Muller WA et al..  2017.  MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair After Myocardial Ischemia Reperfusion Injury.. Circ Res. 121(8):930-940.
2008
Wang Y, Kissenpfennig A, Mingueneau M, Richelme S, Perrin P, Chevrier S, Genton C, Lucas B, DiSanto JP, Acha-Orbea H et al..  2008.  Th2 lymphoproliferative disorder of LatY136F mutant mice unfolds independently of TCR-MHC engagement and is insensitive to the action of Foxp3+ regulatory T cells.. J Immunol. 180(3):1565-75.
1985
Lepay DA, Nathan CF, Steinman RM, Murray HW, Cohn ZA.  1985.  Murine Kupffer cells. Mononuclear phagocytes deficient in the generation of reactive oxygen intermediates.. J Exp Med. 161(5):1079-96.